Antisense oligo to enhance neuronal survival in Huntington’s Disease

by | Jan 20, 2023 | Oh, Youngmi, Yoo, Andrew

— Technology Description

Researchers in Andrew Yoo’s laboratory at Washington University have developed an antisense oligonucleotide targeting a miRNA (miR-29b-3p) as a treatment for Huntington’s disease (HD). Inhibiting miR-29b-3p promotes neuronal survival by rescuing neurons from deg…